ArticleBMC medical imaging2026
Multimodal contrastive learning for non-invasive chondroid bone tumor classification and grading using radiographs.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveDiagnosing and grading chondroid bone tumors with radiography is difficult due to overlapping features with benign conditions such as avascular necrosis and fibrous dysplasia. Histology remains the gold standard, but it is invasive, costly, and not always accessible. This pilot study introduces a contrastive learning framework to address two challenges: (1) developing an AI system for accurate tumor classification and grading using radiographs alone, and (2) creating an enhanced multimodal pipeline when histology is available. MATERIALS AND
methodsWe retrospectively analyzed radiographs from 188 patients and histology images from 63 patients at a tertiary academic medical center in the United States. The stepwise framework included: (1) unimodal classification, (2) contrastive learning to align cross-modal embeddings, and (3) classification using enhanced representations. Models were trained with 5-fold cross-validation and evaluated using AUC, accuracy, sensitivity, and specificity.
resultsOur framework demonstrates promising performance across all tasks. The radiograph-based model achieved an AUC of 0.91 (95%CI: 0.82–1.00) in distinguishing tumors from avascular necrosis and fibrous dysplasia. For grading, contrastive learning improved radiograph-only performance from AUC 0.86 to 0.95 (95%CI: 0.85–1.00). The histology-only model improved from AUC 0.73 to 0.83 with contrastive enhancement. Multimodal integration achieved perfect discrimination (AUC = 1.00) on the available subset.
conclusionThis study establishes proof-of-concept that contrastive learning can effectively bridge radiographic and histological representations for tumor assessment. The framework offers clinical potential by enabling non-invasive classification in resource-limited settings while allowing multimodal enhancement. These results warrant validation in larger, multi-institutional cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.